Non-viral gene therapy offers hope for chronic low back pain sufferers

FHS
May 20, 2024
8:48 am

A novel non-viral gene therapy for discogenic back pain (DBP).

Irish startup reports mid-stage victory for short-acting psychedelic drug in depression

GH Research has shared compelling data in people with a traditionally challenging form of depression who were dosed with its psychedelic candidate, despite the drug

February 4, 2025

Alarmed by popularity of Ozempic and Wegovy, insurers wage multi-front battle

Patients are bracing for “D-Day,” the date their insurance companies will stop covering the drugs. Doctors are getting letters from insurance investigators discouraging new prescriptions.

August 3, 2023

Trump administration cancels meetings of health technology advisory committee

The Trump administration has indefinitely canceled meetings of a health technology advisory committee responsible for helping to formulate rules around the use of data and

January 29, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.